During the past decade, Kardiologische Praxis Northeim conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 2 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Kardiologische Praxis Northeim" are "Cardiovascular Disease" (2 trials), "Atherosclerotic Cardiovascular Disease" (1 trials), "Atrial Fibrillation" (1 trials), "Cardiovascular Diseases" (1 trials) and "Dyslipidemic" (1 trials). Many other conditions were trialed in "Kardiologische Praxis Northeim" in a lesser frequency.

Most popular intervention types in "Kardiologische Praxis Northeim" are "Drug" (3 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "bococizumab (PF-04950615)" (2 trials), "Edoxaban" (1 trials) and "Non-interventional" (1 trials). Other intervention names were less common.

The vast majority of trials in "Kardiologische Praxis Northeim" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Kardiologische Praxis Northeim". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Kardiologische Praxis Northeim, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Kardiologische Praxis Northeim, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".